Clinical Trials Browser

Phase 3 × Terminated × lanreotide × Clear all

NCT02683941 2022-07-06

SPINET

Phase 3 Terminated

77 enrolled 20 charts

Neuroendocrine Tumors in Lung

NCT01313273 2019-11-22

POSEIDON

Phase 3 Terminated

3 enrolled 4 charts

Prostatic Neoplasms